Diagnosis and treatment of pancreatic vasoactive intestinal peptide endocrine tumors

Pancreas

Volumn 38, Issue 7, 2009, Pages 811-814

  Song, Shaowei ^a   Shi, Rui ^a   Li, Baifeng ^a   Liu, Yongfeng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Hepatic metastasis; Octreotide; Pancreatic vasoactive intestinal peptide secreting tumors; Surgical procedure

Indexed keywords

FLUOROURACIL; OCTREOTIDE; POTASSIUM; STREPTOZOCIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; DIARRHEA; DIFFERENTIAL DIAGNOSIS; ELECTROLYTE DISTURBANCE; ENDOCRINE TUMOR; FEMALE; FOLLOW UP; HUMAN; HYPOKALEMIA; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; LIVER METASTASIS; MALE; PANCREAS RESECTION; PANCREAS TUMOR; PANCREATICODUODENECTOMY; POSTOPERATIVE CARE; POTASSIUM BLOOD LEVEL; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR DIAGNOSIS; VIPOMA;

ADULT; CHROMOGRANIN A; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; VASOACTIVE INTESTINAL PEPTIDE; VIPOMA;

EID: 70349925377     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181b2bc7c     Document Type: Article

References (21)

1. Friesen SR. Update on the diagnosis and treatment of rare neuroendocrine tumors. Surg Clin North Am. 1987;67(2): 379-393.
2. Peng SY, Li JT, Liu YB, et al. Diagnosis and treatment of VIPoma in China: (case report and 31 case reviews) diagnosis and treatment of VIPoma. Pancreas. 2004;28(1):93-97. (Pubitemid 38032252)
3. Soga J, Yakuwa Y. VIPoma/diarrheogenic syndrome: a statistical evaluation of 241 reported cases. J Exp Clin Cancer Res. 1998;17(4): 389-400. (Pubitemid 29083408)
4. Grier JF. WDHA (watery diarrhea, hypokalemia, achlorhydria) syndrome: clinical features, diagnosis, and treatment. South Med J. 1995;88(1):22-24.
5. Matuchansky C, Rambaud JC. VIPomas and endocrine cholera: clinical presentation, diagnosis and advances in management. In: Mignon M, Jensen RT, eds. Endocrine Tumors of the Pancreas. Bâle, Switzerland: Karger; 1995: 166-182.
6. Rood RP, DeLellis RA, Dayal Y, et al. Pancreatic cholera syndrome due to vasoactive intestinal polypeptide-producing tumor: further insights into the pathophysiology. Gastroenterology. 1988;94(3): 813-818. (Pubitemid 18073547)
7. O'Dorisio TM, Mehkjian HS, Gaginella TS. Medical therapy of VIPomas. Endocrinol Metab Clin North Am. 1989;18(2): 545-546.
8. Maton PN, O'Dorisio TM, Howe BA, et al. Effect of a long-acting somatostatin analogue (SMS 201Y995) in a patient with pancreatic cholera. N Engl J Med. 1985;312(1):17-21.
9. Krejs GJ. VIPoma syndrome. Am J Med. 1987;82(5B):37-48.
10. Park SK, O'Dorisio MS, O'Dorisio TM. Vasoactive intestinal polypeptide-secreting tumours: biology and therapy. Baillieres Clin Gastroenterol. 1996;10(4):673-696.
11. Schlienger JI. Endocrine tumors of the pancreas. Ann Endocrinol (Paris). 2005;66(1):64-68.
12. Wang L, Zhao YP, Lee CI, et al. Diagnosis and treatment of malignant pancreatic endocrine tumor. Chin Med Sci J. 2004;19(2): 130-133. (Pubitemid 38901906)
13. Nguyen HN, Backes B, Lammert F, et al. Long-term survival after diagnosis of hepatic metastatic VIPoma: report of two cases with disparate courses and review of therapeutic options. Dig Dis Sci. 1999;44(6):1148-1155. (Pubitemid 29297219)
14. Schoevaerdts D, Favet L, Zekry D, et al. VIPoma: effective treatment with octreotide in the oldest old. J Am Geriatr Soc. 2001;49(4): 496-497. (Pubitemid 32390894)
15. Remme CA, de Groot GH, Schrijver G. Diagnosis and treatment of VIPoma in a female patient. Eur J Gastroenterol Hepatol. 2006; 18(1):93-99. (Pubitemid 43004889)
16. Nikou GC, Toubanakis C, Nikolaou P, et al. VIPomas: an update in diagnosis and management in a series of 11 patients. Hepatogastroenterology. 2005;52(64):1259-1265. (Pubitemid 40942228)
17. Falconi M, Bettini R, Boninsegan L, et al. Surgical strategy in the treatment of pancreatic neuroendocrine tumors. JOP. 2006;7(1): 150-156.
18. Case CC, Wirfel K, Vassilopoulou-Sellin R. Vasoactive intestinal polypeptide-secreting tumor (VIPoma) with liver metastases: dramatic and durable symptomatic benefit from hepatic artery embolization, a case report. Med Oncol. 2002;19(3):181-187. (Pubitemid 35370337)
19. Udelsman R, Yeo CJ, Hruban RH, et al. Pancreaticoduodenectomy for selected pancreatic endocrine tumors. Surg Gynecol Obstet. 1993; 177(3):269-278. (Pubitemid 23262675)
20. Moug SJ, Leen E, Horgan PG, et al. Radiofrequency ablation has a valuable therapeutic role in metastatic VIPoma. Pancreatology. 2006;6(1-2):155-159.
21. Hengst K, Nashan B, Avenhaus W, et al. Metastatic pancreatic VIPoma: deteriorating clinical course and successful treatment by liver transplantation. Z Gastroenterol. 1998;36(3):239-245. (Pubitemid 28172487)